CrushSCI.com
126.8Average days
119Median days
4Fastest days
288Longest days
1332025 publications

Paper Review Records

All Paper Review Records

24 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

96 days

Strengthening Signal Detection by Proactive Adverse Event Case Identification in Electronic Health Records Using a Text-Mining Tool

Authors
Gabriëlla von Kreijfelt; Juliëtte Zwaveling; Jette A. van Lint; Loes E. Visser; Agnes C. KantShow moreShow less
Affiliations
1. The Netherlands Pharmacovigilance Centre Lareb, ‘s-Hertogenbosch, The Netherlands; 2. Department of Clinical Pharmacology and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands; 3. Department of Pharmacy, Haga Teaching Hospital, The Hague, The Netherlands; 4. Hospital Pharmacy, Erasmus Medical Centre, Rotterdam, The NetherlandsShow moreShow less
Source PDF DOI Publisher page
88 days

Current Pharmacovigilance Outsourcing Practices in Arab Countries

Authors
Ibrahim Abdeldayem; Thamir M Alshammari; Karine PalinShow moreShow less
Affiliations
1. Arriello s.r.o, Prague, Czech Republic; 2. Eu2P Programme, Université de Bordeaux, Bordeaux, France; 3. Department of Pharmacy Practice, College of Pharmacy, Jazan University, Jazan, Saudi Arabia; 4. Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan, Saudi ArabiaShow moreShow less
Source PDF DOI Publisher page
108 days

Reassessing the Neoplasm Signal with Fezolinetant: Regulatory Inference, Mechanistic Plausibility, and the Case for Proactive Pharmacovigilance

Authors
Glen Clack; Jennifer RenwickShow moreShow less
Affiliations
1. Ailse Oncology Ltd and University of Sheffield Medical School, Sheffield, Truro, UK; 2. Independent Pharmaceutical Consultant, London, UKShow moreShow less
Source PDF DOI Publisher page
87 days

Safety Monitoring of COVID-19 Vaccines in the Vaccine Adverse Event Reporting System (VAERS): United States, August 22, 2024–July 4, 2025

Authors
Brittney Romanson; Pedro L. Moro; Penelope Strid; Anne Hause; Erin Stroud; Paige L. Marquez; Bicheng Zhang; Carol Ennulat; Hannah Brown; John R. SuShow moreShow less
Affiliations
1. Division of Healthcare Quality and Promotion, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC), Atlanta, USA; 2. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, CanadaShow moreShow less
Source PDF DOI Publisher page
4 days

ISoP MENA Chapter: Strategic Development and Future Directions Following a Decade of Strengthening Pharmacovigilance in the Middle East and North Africa

Authors
Hadir Rostom; Mohamed A. Elhawary; Mayada Alkhakany; Manal M. Younus; Thamir Alshammari; Felipe Villalobos; Omar AimerShow moreShow less
Affiliations
1. ISoP MENA Chapter Founding Group, Cairo, Egypt; 2. Faculty of Pharmacy, MSA University, 6th of October City, Egypt; 3. International Society of Pharmacovigilance, ISoP Secretariat Ltd, London, UK; 4. Medical Affairs, SAJA Pharmaceuticals Co., Ltd, Jeddah, Saudi Arabia; 5. Seven D Consultancy, Dubai, UAE; 6. Iraqi Pharmacovigilance Centre, Ministry of Health, Baghdad, Iraq; 7. Department of Pharmacy Practice, College of Pharmacy, Jazan University, Jazan, Saudi Arabia; 8. Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan, Saudi Arabia; 9. Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain; 10. InnoVigilance, Laval, CanadaShow moreShow less
Source PDF DOI Publisher page
288 days

Safety and Management of Targeted Therapies for Relapsed/Refractory Chronic Lymphocytic Leukemia

Authors
Sikander Ailawadhi; Elcin Omercikoglu; Aneel Paulus; Ricardo D. Parrondo; Asher A. Chanan-KhanShow moreShow less
Affiliations
1. Division of Hematology-Oncology, Mayo Clinic, Jacksonville, USA; 2. Department of Cancer Biology, Mayo Clinic, Jacksonville, USAShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.